Vanderbilt University Hospital Medical Center (VUMC) is the first hospital in Tennessee to introduce Optellum's Virtual Nodule Clinic. The world-leading hospital was one of the first to conduct clinical trials…
A new artificial intelligence software that will help doctors to make quicker and more accurate decisions when diagnosing potentially cancerous lung lesions, has received major government funding. This is a…
Professor Sam Janes, a leading clinician and University College London academic will presenting a poster to American Society of Clinical Oncology (ASCO) annual meeting on identifying adenocarcinoma with AI. Collaborators include Vanderbilt University Medical Center,…
Join us on June 23rd at 1pm EST for a webinar where expert clinical speakers will discuss the evidence, clinically-validated in multi center studies, and a case study in implementation…
Optellum is excited to be working with a leading hospital on the first clinical installation of Virtual Nodule Clinic (VNC). Over the past 8 months, Optellum's Virtual Nodule Clinic (VNC)…
Optellum has been collaborating with Oxford University Hospitals and UMC Groningen to evaluate the ability of our AI to assist in lung cancer screening workflows. A paper published in European…
Virtual Nodule Clinic empowers clinicians to make optimal clinical decisions in early-stage lung cancer diagnosis and is now commercially available in the United States. Oxford, United Kingdom – March 23,…
2020 was an extraordinary year and, looking back, while it was dominated by the world health crisis of the pandemic there were also colossal achievements in healthcare and medical technology;…
Dr Vachani presented a virtual poster as a three-minute video as part of a session that highlighted lung cancer projects across the continuum of care.
Global leading doctors from Vanderbilt and Oxford have published independent clinical validation of the Optellum Lung Cancer Prediction AI, illustrating its potential to shorten time to diagnosis. The paper, with…
The Optellum artificial intelligence prediction model has been demonstrated to outperform the best currently used model. Prediction of the likelihood of malignancy is central to the clinical management of suspicious…
Healthcare in Europe covered the launch of the LUCINDA project funded by EIT Health and the beginning of Optellum's work. This includes an interview with Professor Hans-Ulrich Kauczor, Medical Director…